Hinokitiol

58% of ICU Patients Show Zinc Deficiency - Dr Zinx - Hinokitiol Increases Zinc Uptake

Retrieved on: 
Tuesday, September 1, 2020

This study may show it necessary for patients coming into the ICU to be treated for Zinc deficiency and action taken to restore the number of zinc transporters.

Key Points: 
  • This study may show it necessary for patients coming into the ICU to be treated for Zinc deficiency and action taken to restore the number of zinc transporters.
  • Zinc deficiency negatively impacts the growth and function of B and T cells, central effectors of the adaptive immune system.
  • The potent synergistic interaction of Zinc and Hinokitiol has been demonstrated to inhibit the replication of RNA viruses in vitro.
  • Hinokitiol acts as a Zinc ionophore, rapidly increasing the import of extracellular Zinc into cells, thus inhibiting viral replication.

World's First Zinc Ionophore Oral Spray Launches in the EU

Retrieved on: 
Saturday, August 1, 2020

MILAN, Aug. 1, 2020 /PRNewswire/ -- Dr ZinXhas launchedtheir Patent Pending Zinc + Hinokitiol Oral Sprayacross Amazon EU today.

Key Points: 
  • MILAN, Aug. 1, 2020 /PRNewswire/ -- Dr ZinXhas launchedtheir Patent Pending Zinc + Hinokitiol Oral Sprayacross Amazon EU today.
  • This is the first time a Zinc Ionophoreoral spray combination has been available to the EU market.
  • "A combination of Zinc Salts and Hinokitiol can be applied as an inexpensive, effective and safe alternative approach to fight respiratory viruses.
  • "-Dr Nikola Kolundzic, Kings College London
    Following wide publication and support from PresidentTrump for the use of a Hydroxychloroquine+ Zinc Combination, Zinc has come under increasing interest.